MedPath

Effects of exercise training with power control in muscle strength, cholesterol and body fat postmenopausal wome

Not Applicable
Conditions
Menopausal women. Sedentary Lifestyle
N95.1
F01.829.458.705
Registration Number
RBR-9cbp8s
Lead Sponsor
niversidade Estadual Paulista - UNESP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Female volunteers; aged between 50 and 65 years; present in the menopausal period without menstruation for 1 year or more; possess a medical certificate to perform the tests required and participate in the training program.

Exclusion Criteria

Present physical limitations or any health problems that prevent the implementation of the evaluation or bodily practices; accumulate three consecutive unexcused absences or 4 unexcused absences during the month of intervention.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Statistically significant improvement (p value less than 0.05) of the variables of body composition after 16 weeks of training. Furthermore, it is expected that the effect promoted by this training program remain for a long time (6 months or 1 years).;Because it is a finished research, we observed statistically significant improvement (p value less than 0.05) of body composition variables after 16 weeks of training. The maintenance of body composition values occurred for the body fat variable (persistence of the effects in time 6 months or 1 year). However, for the variable body composition (lean mass) there was no persistence.
Secondary Outcome Measures
NameTimeMethod
Improvement of the level of physical activity, cardiorespiratory fitness and eating habits.;Because it is a finished research, we observed statistically significant improvement (p value less than0.05) the standard variable food and practice regular physical activity, and observed the maintenance of these variables (persistence of the effects in time 6 months or 1 year).
© Copyright 2025. All Rights Reserved by MedPath